Search for: "NOVARTIS PHARMACEUTICALS CORP."
Results 1 - 20
of 366
Sort by Relevance
|
Sort by Date
1 May 2024, 1:18 pm
Novartis AG, the 2011 opinion of the U.S. [read post]
16 Apr 2024, 8:42 am
Cir. 2019) and Novartis Pharmaceuticals Corp. v. [read post]
3 May 2023, 3:28 pm
Purdue Research Foundation secured rights to royalties from Pluvicto as a result of Purdue’s license agreement with Endocyte Corp., which was acquired by Novartis in 2018. [read post]
10 Feb 2023, 11:58 am
Novartis Pharmaceuticals Corp. v. [read post]
11 Nov 2022, 9:40 am
Novartis Pharmaceuticals Corp., Case No. 17-cv-04405-HSG, Document 565, July 22,2021 (N.D. [read post]
26 Sep 2022, 4:49 am
Corp. v. [read post]
22 Sep 2022, 9:54 am
Most recently, Novartis AG plans to appeal a case to the U.S. [read post]
9 Aug 2022, 5:53 pm
Corp. v. [read post]
7 Aug 2022, 9:15 am
That is precisely what the Federal Circuit did for HEC Pharm Co. recently in Novartis Pharmaceuticals Corp. v. [read post]
7 Aug 2022, 9:15 am
That is precisely what the Federal Circuit did for HEC Pharm Co. recently in Novartis Pharmaceuticals Corp. v. [read post]
12 Jul 2022, 2:08 am
Corp. v. [read post]
21 Jun 2022, 9:46 pm
Noonan -- The Federal Circuit recently granted a panel rehearing and vacated a panel decision between these parties decided earlier this year (see Novartis Pharmaceuticals Corp. v. [read post]
21 Jun 2022, 2:18 pm
Court of Appeals for the Federal Circuit issued a precedential decision in Novartis Pharmaceuticals Corp. v. [read post]
21 Jun 2022, 2:18 pm
Court of Appeals for the Federal Circuit issued a precedential decision in Novartis Pharmaceuticals Corp. v. [read post]
19 Mar 2022, 2:09 pm
Risk assessments would seemingly be about assessing risks, but they are not. [read post]
14 Mar 2022, 2:46 pm
Corp. v. [read post]
4 Jan 2022, 8:39 pm
This is a question that comes readily to mind when reading the Federal Circuit's opinion (and Chief Judge Moore's dissent) in Novartis Pharmaceuticals Corp. v. [read post]
12 Dec 2021, 2:22 pm
Novartis Pharms. [read post]
17 Sep 2021, 12:18 pm
’” The court emphasized that evidence of “motivation to combine” and “expectation of success” are separate legal requirements, citing its 2019 decision in Novartis Pharmaceuticals Corp. v. [read post]
5 Aug 2021, 12:12 pm
Corp., 785 F.3d 625, 631 (Fed. [read post]
